Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-30

Clinical Trial Update: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes [NA]

View source ↗

Summary

Clinical trial update evaluating the use of flash continuous glucose monitoring to reduce hyperglycemia in people with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Diabetes Care | Conditions: Diabetes Mellitus, Type 2 | NA | Status: UNKNOWN